Trial intelligence / Profile preview

Tarivid ointment for epistaxis during nasotracheal intubation in children

NCT04426409Completed

Sponsor
Ajou University School of Medicine
Start
Jul 2020
Primary completion
Sep 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of ofloxacin in epistaxis (2 arms), sponsored by Ajou University School of Medicine. Primary endpoints: Incidence of epistaxis immediate after intubation and Incidence of epistaxis immediate after extubation. Started Jul 2020; status: completed.

02

Drugs

ofloxacin
03

Conditions

epistaxis

Beyond the preview

Go deeper on NCT04426409.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04426409.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call